Activation of peripheral leukocyte migration before spontaneous labor at term.


Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
Nov 2024
Historique:
received: 29 12 2022
revised: 12 02 2024
accepted: 20 02 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: ppublish

Résumé

Leukocytes are induced to migrate into the uterus at parturition, releasing cytokines and chemokines that activate it for delivery. A specific chemotactic signal is required for these actions, and published evidence suggests that it comes from the human fetal membranes and has a time-dependent component (ie, cells obtained at term in labor migrate more than cells obtained at term not yet in labor). The hypothesis that the fetal membrane chemoattractants activate the leukocytes to become responsive for migration was tested. This study aimed to: (1) examine the changes in leukocyte migration-responsiveness longitudinally from the late third trimester, to in labor, to 3 days postpartum; (2) explore the specific week-to-week changes in migration before delivery; (3) define the timing of chemokine receptor expression patterns in leukocytes relative to migration and the changes in cytokine and chemokine concentrations in maternal serum; (4) examine the ability of term fetal membrane-conditioned medium and term maternal serum to increase cell responsiveness; and (5) test the potential of the leukocyte migration assay to predict delivery within 1 week. Leukocyte migration in response to a chemoattractive extract of term human fetal membranes was studied using a modified Boyden chamber. Flow cytometry assessed migrated cell phenotypes. The relationship between the expression of chemokine receptors and migration was tested using quantitative polymerase chain reaction, the bioassay, and regression analyses. Cytokines and chemokines in maternal serum were quantified using multiplex analysis. Conditioned medium from fetal membrane explants and maternal serum were evaluated for their abilities to enhance leukocyte migration using the bioassay. The ability of the bioassay to predict term delivery was assessed using receiver-operating characteristic curve and cost-curve analysis. The number of leukocytes that migrated at term delivery was increased relative to the late third trimester, followed by a significant fall in numbers that migrated at 3 days postpartum (P=.002). The largest increase in migrated cells occurred 1 to 2 weeks before delivery. The messenger RNA abundance of several chemokine receptors increased in peripheral leukocytes at term in labor relative to the third trimester, and this correlated with an increase in migrated cells in 5 of 6 cases (R=0.589 to 0.897; P<.03). The concentrations of several chemokines and cytokines in maternal serum increased with labor onset. Fetal membrane explant-conditioned medium and maternal serum obtained at term labor increased the responsiveness of leukocytes to fetal membrane chemoattractive extract. The bioassay was demonstrated to predict delivery within 7 days with excellent performance characteristics using a cohort prevalence of 71.7% (positive predictive value=96.1%; negative predictive value=58.5%; sensitivity=74.2%; specificity=92.3%; positive likelihood ratio=9.25; and negative likelihood ratio=0.28). A single determination was validated to have a high degree of confidence. Term human fetal membranes release chemoattractants near the end of pregnancy that increase in ability to activate and attract an increasing number of leukocytes as gestation advances.

Sections du résumé

BACKGROUND BACKGROUND
Leukocytes are induced to migrate into the uterus at parturition, releasing cytokines and chemokines that activate it for delivery. A specific chemotactic signal is required for these actions, and published evidence suggests that it comes from the human fetal membranes and has a time-dependent component (ie, cells obtained at term in labor migrate more than cells obtained at term not yet in labor). The hypothesis that the fetal membrane chemoattractants activate the leukocytes to become responsive for migration was tested.
OBJECTIVE OBJECTIVE
This study aimed to: (1) examine the changes in leukocyte migration-responsiveness longitudinally from the late third trimester, to in labor, to 3 days postpartum; (2) explore the specific week-to-week changes in migration before delivery; (3) define the timing of chemokine receptor expression patterns in leukocytes relative to migration and the changes in cytokine and chemokine concentrations in maternal serum; (4) examine the ability of term fetal membrane-conditioned medium and term maternal serum to increase cell responsiveness; and (5) test the potential of the leukocyte migration assay to predict delivery within 1 week.
STUDY DESIGN METHODS
Leukocyte migration in response to a chemoattractive extract of term human fetal membranes was studied using a modified Boyden chamber. Flow cytometry assessed migrated cell phenotypes. The relationship between the expression of chemokine receptors and migration was tested using quantitative polymerase chain reaction, the bioassay, and regression analyses. Cytokines and chemokines in maternal serum were quantified using multiplex analysis. Conditioned medium from fetal membrane explants and maternal serum were evaluated for their abilities to enhance leukocyte migration using the bioassay. The ability of the bioassay to predict term delivery was assessed using receiver-operating characteristic curve and cost-curve analysis.
RESULTS RESULTS
The number of leukocytes that migrated at term delivery was increased relative to the late third trimester, followed by a significant fall in numbers that migrated at 3 days postpartum (P=.002). The largest increase in migrated cells occurred 1 to 2 weeks before delivery. The messenger RNA abundance of several chemokine receptors increased in peripheral leukocytes at term in labor relative to the third trimester, and this correlated with an increase in migrated cells in 5 of 6 cases (R=0.589 to 0.897; P<.03). The concentrations of several chemokines and cytokines in maternal serum increased with labor onset. Fetal membrane explant-conditioned medium and maternal serum obtained at term labor increased the responsiveness of leukocytes to fetal membrane chemoattractive extract. The bioassay was demonstrated to predict delivery within 7 days with excellent performance characteristics using a cohort prevalence of 71.7% (positive predictive value=96.1%; negative predictive value=58.5%; sensitivity=74.2%; specificity=92.3%; positive likelihood ratio=9.25; and negative likelihood ratio=0.28). A single determination was validated to have a high degree of confidence.
CONCLUSION CONCLUSIONS
Term human fetal membranes release chemoattractants near the end of pregnancy that increase in ability to activate and attract an increasing number of leukocytes as gestation advances.

Identifiants

pubmed: 39442996
pii: S0002-9378(24)00360-0
doi: 10.1016/j.ajog.2024.02.280
pii:
doi:

Substances chimiques

Cytokines 0
Receptors, Chemokine 0
Chemokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

539.e1-539.e13

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Han Lee (H)

Department of Physiology, University of Alberta, Edmonton, Canada.

Ai Takamizu (A)

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Yuji Nishizaki (Y)

Medical Technology Innovation Center, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Naotake Yanagisawa (N)

Medical Technology Innovation Center, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Shuko Nojiri (S)

Medical Technology Innovation Center, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Atsuo Itakura (A)

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Nanlin Yin (N)

Department of Obstetrics and Gynecology, Chongqing Medical University, Chongqing, China.

Zheng Liu (Z)

Department of Obstetrics and Gynecology, Chongqing Medical University, Chongqing, China.

Lulu Wang (L)

Department of Obstetrics and Gynecology, Chongqing Medical University, Chongqing, China.

Yuxin Ran (Y)

Department of Obstetrics and Gynecology, Chongqing Medical University, Chongqing, China.

Jenelle Chen (J)

Department of Physiology, University of Alberta, Edmonton, Canada.

Kelycia B Leimert (KB)

Department of Physiology, University of Alberta, Edmonton, Canada.

Shintaro Makino (S)

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Satoru Takeda (S)

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Hongbo Qi (H)

Department of Obstetrics and Gynecology, Chongqing Medical University, Chongqing, China.

Jun Takeda (J)

Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

David M Olson (DM)

Departments of Obstetrics and Gynecology and Pediatrics and Physiology, University of Alberta, Edmonton, Canada. Electronic address: dmolson@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH